Abstract Details

Title Psychiatric Symptoms and Mental Health Co-Morbidities in Individuals Living with Parkinson's Disease (PD) across the Continuum of Care

Topic Movement Disorders

Presentation(s) P04 - (-)

Poster/Presentation
Number 172

Objective

Background BACKGROUND: PD is a neurodegenerative disorder with a higher prevalence in older adults. Individuals with PD experience psychiatric symptoms that add to the health impact of the condition.

Design/Methods DESIGN/METHODS: Psychiatric symptoms were examined with data from interRAI assessments that are used as part of normal clinical practice in the home care (HC), nursing home (NH), and complex continuing care (CCC) settings in Canada. Data for residential care settings were obtained through the Canadian Institute for Health Information's Continuing Care Reporting System. Using the most recent assessment to identify distinct individuals, there were 20,057 individuals with PD (compared with 146,338 without neurological disorders) in 984 NHs in 7 provinces, and 173 CCC hospitals/units in Ontario. Data for HC settings were restricted to Ontario using the most recent assessments for 19,581 persons with PD (compared to 321,798 without neurological disorders) among long stay HC clients assessed by Community Care Access Centre (CCAC) case managers) in 14 CCACs.

Results RESULTS: Among long stay HC clients, rates of anxiety, delirium, aggressive behaviour, hallucinations/delusions, and use of antipsychotics and antidepressants were significantly higher in individuals with PD compared to the control group. In the NH and CCC settings, rates of aggressive behaviour, hallucinations/delusions, physical restraint use, and antipsychotic and antidepressant use remained significantly higher in individuals with PD. Aggressive behaviour (40.4%) and antipsychotic use (33.6%) were highest in NHs. Restraint use occurred at triple the rate for persons with PD compared with those without neurological disorders in NHs.

Conclusions CONCLUSIONS: Across the continuum of care, individuals with PD have higher rates of aggressive behaviour, and antipsychotic and physical restraint use than controls, raising concerns about the management of these symptoms in individuals with PD in primary care.

Authors/Disclosures
Tamara M. Pringsheim, MD, FAAN (Mathison Centre) PRESENTER	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Nathalie Jette, MD, MSc, FRCPC, FAAN (University of Calgary)	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
	No disclosure on file
Bruce Bean	No disclosure on file
Jordan S. Dubow, MD	Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .

��ɫ��

��ɫ��